Literature DB >> 2002037

Thiocyanate is the major substrate for eosinophil peroxidase in physiologic fluids. Implications for cytotoxicity.

A Slungaard1, J R Mahoney.   

Abstract

The potent cytotoxic capacity of eosinophils for parasites and host tissue has in part been attributed to the catalytic action of eosinophil peroxidase (EPO), which preferentially oxidizes Br- to the powerful bleaching oxidant HOBr in buffers that mimic serum halide composition (100 mM Cl-, 20-100 microM Br-, less than 1 microM I-). However, serum also contains 20-120 microM SCN-, a pseudohalide whose peroxidative product, HOSCN, is a weak, primarily sulfhydryl-reactive oxidant. Because of its relative abundance and high oxidation potential, we hypothesized that SCN-, not Br- or I-, is the major substrate for EPO in physiologic fluids. We find that in Earle's buffer (100 mM Cl-) supplemented with 100 microM Br- and varying concentrations of SCN-, HOBr production by activated eosinophils and purified EPO, assayed by conversion of fluorescein to dibromofluorescein, was 50% inhibited (ID50) by only 1 microM SCN-. SCN- also blocked (ID50 10 microM) EPO oxidation of I- to HOI, assayed as iodofluorescein, despite the presence of 100 microM (i.e. grossly supraphysiologic) I-. Thionitrobenzoic acid oxidation kinetics indicate that SCN- is the initial species oxidized by EPO in equimolar mixtures of SCN- and Br- and in human serum. EPO also catalyzed the covalent incorporation of [14C]SCN- into proteins in buffers regardless of Br- concentration and in human serum. Comparing the cytotoxicity of HOSCN and HOBr for host cells, we find that even subphysiologic concentrations of SCN- (3.3-10 microM) nearly completely abrogate the potent Br(-)-dependent toxicity of EPO for 51Cr-labeled aortic endothelial cells and isolated working rat hearts, recently developed models of eosinophilic endocarditis. Thus, HOSCN, hitherto best known as a bacteriostatic agent in saliva and milk, is likely also the major oxidant produced by EPO in physiologic fluids, and the presence of SCN- averts damage to EPO-coated host tissues that might otherwise accrue as a result of HOBr generation. In view of these findings, the potential role of HOSCN in eosinophil killing of parasitic pathogens deserves close examination.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2002037

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  29 in total

Review 1.  Eosinophil-dependent bromination in the pathogenesis of asthma.

Authors:  J W Heinecke
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

2.  Protein Radical Formation Resulting from Eosinophil Peroxidase-catalyzed Oxidation of Sulfite.

Authors:  Kalina Ranguelova; Saurabh Chatterjee; Marilyn Ehrenshaft; Dario C Ramirez; Fiona A Summers; Maria B Kadiiska; Ronald P Mason
Journal:  J Biol Chem       Date:  2010-05-25       Impact factor: 5.157

3.  Toxicity of eosinophil MBP is repressed by intracellular crystallization and promoted by extracellular aggregation.

Authors:  Alice Soragni; Shida Yousefi; Christina Stoeckle; Angela B Soriaga; Michael R Sawaya; Evelyne Kozlowski; Inès Schmid; Susanne Radonjic-Hoesli; Sebastien Boutet; Garth J Williams; Marc Messerschmidt; M Marvin Seibert; Duilio Cascio; Nadia A Zatsepin; Manfred Burghammer; Christian Riekel; Jacques-Philippe Colletier; Roland Riek; David S Eisenberg; Hans-Uwe Simon
Journal:  Mol Cell       Date:  2015-02-26       Impact factor: 17.970

4.  rhEPO (recombinant human eosinophil peroxidase): expression in Pichia pastoris and biochemical characterization.

Authors:  Chiara Ciaccio; Alessandra Gambacurta; Giampiero De Sanctis; Domenico Spagnolo; Christina Sakarikou; Giovanni Petrella; Massimo Coletta
Journal:  Biochem J       Date:  2006-04-15       Impact factor: 3.857

Review 5.  Biochemical mechanisms and therapeutic potential of pseudohalide thiocyanate in human health.

Authors:  Joshua D Chandler; Brian J Day
Journal:  Free Radic Res       Date:  2015-01-28

6.  Comparison of human red cell lysis by hypochlorous and hypobromous acids: insights into the mechanism of lysis.

Authors:  M C Vissers; A C Carr; A L Chapman
Journal:  Biochem J       Date:  1998-02-15       Impact factor: 3.857

7.  Myeloperoxidase in chronic kidney disease.

Authors:  A Madhusudhana Rao; Usha Anand; C V Anand
Journal:  Indian J Clin Biochem       Date:  2010-09-14

8.  Eosinophil Peroxidase Catalyzed Protein Carbamylation Participates in Asthma.

Authors:  Zeneng Wang; Joseph A DiDonato; Jennifer Buffa; Suzy A Comhair; Mark A Aronica; Raed A Dweik; Nancy A Lee; James J Lee; Mary Jane Thomassen; Mani Kavuru; Serpil C Erzurum; Stanley L Hazen
Journal:  J Biol Chem       Date:  2016-09-01       Impact factor: 5.157

9.  Inactivation of thiol-dependent enzymes by hypothiocyanous acid: role of sulfenyl thiocyanate and sulfenic acid intermediates.

Authors:  Tessa J Barrett; David I Pattison; Stephen E Leonard; Kate S Carroll; Michael J Davies; Clare L Hawkins
Journal:  Free Radic Biol Med       Date:  2012-01-08       Impact factor: 7.376

10.  Probing the role of active site histidine residues in the catalytic activity of lacrimal gland peroxidase.

Authors:  Abhijit Mazumdar; Debashis Bandyopadhyay; Uday Bandyopadhyay; Ranajit K Banerjee
Journal:  Mol Cell Biochem       Date:  2002-08       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.